Who is sponsoring STERNOCAT?

STERNOCAT is sponsored by Assistance Publique - Hôpitaux de Paris.

What condition does STERNOCAT study?

STERNOCAT studies Pneumonia, Cardiac Surgery, Multiperforated Catheter, Analgesia, Critical Care Medicine.

What drugs are being tested in STERNOCAT?

Interventions: L bupivacaine, placebo.

What is the status of STERNOCAT?

STERNOCAT is currently COMPLETED.

Last reviewed 2015-04-23 · How we verify

Cicatricial Analgesia Catheters Outcome on Bronchopulmonary Infection Number With Sternotomy Cardiac Operated (STERNOCAT)

NCT01648777 Phase 3 COMPLETED

Pneumonia occurs frequently in patients undergoing cardiac surgery and allows to increase their mortality. While chest physical therapy plays a crucial role to prevent postoperative pneumoniae, painful mobilization of the sternum after sternotomy limits chest physical therapy. The continuous local anesthetic infusion by multiperforated catheter decreases sternum pain. Because of this optimal pain management, early chest physical therapy could be more efficient and could contribute to decrease the rate of pneumonia. The aim of this study is to test if management of sternotomy pain using continuous local anesthetic infusion by multiperforated catheter may contribute to decrease the rate of perioperative pneumonia.

Details

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	Phase 3
Status	COMPLETED
Enrolment	1502
Start date	2012-03
Completion	2015-01

Conditions

Pneumonia
Cardiac Surgery
Multiperforated Catheter
Analgesia
Critical Care Medicine

Interventions

L bupivacaine
placebo

Primary outcomes

Rate of post-operative pneumonia in hospital — 30 days

Countries

France